GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ypsomed Holding AG (XSWX:YPSN) » Definitions » Operating Cash Flow per Share

Ypsomed Holding AG (XSWX:YPSN) Operating Cash Flow per Share : CHF11.96 (TTM As of Mar. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Ypsomed Holding AG Operating Cash Flow per Share?

Ypsomed Holding AG's operating cash flow per share for the six months ended in Mar. 2024 was CHF6.58. Ypsomed Holding AG's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was CHF11.96.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Ypsomed Holding AG was 23.90% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 20.80% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 23.40% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 10.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Ypsomed Holding AG's Operating Cash Flow per Share or its related term are showing as below:

XSWX:YPSN' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -91.5   Med: 5.2   Max: 144.3
Current: 20.8

During the past 13 years, Ypsomed Holding AG's highest 3-Year average Operating Cash Flow per Share Growth Rate was 144.30% per year. The lowest was -91.50% per year. And the median was 5.20% per year.

XSWX:YPSN's 3-Year OCF Growth Rate is ranked better than
74.67% of 687 companies
in the Medical Devices & Instruments industry
Industry Median: 2.6 vs XSWX:YPSN: 20.80

Ypsomed Holding AG Operating Cash Flow per Share Historical Data

The historical data trend for Ypsomed Holding AG's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ypsomed Holding AG Operating Cash Flow per Share Chart

Ypsomed Holding AG Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Operating Cash Flow per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.88 6.78 6.78 9.65 11.96

Ypsomed Holding AG Semi-Annual Data
Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Operating Cash Flow per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.98 5.28 4.39 5.38 6.58

Competitive Comparison of Ypsomed Holding AG's Operating Cash Flow per Share

For the Medical Instruments & Supplies subindustry, Ypsomed Holding AG's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ypsomed Holding AG's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ypsomed Holding AG's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Ypsomed Holding AG's Price-to-Operating-Cash-Flow falls into.



Ypsomed Holding AG Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Ypsomed Holding AG's Operating Cash Flow per Share for the fiscal year that ended in Mar. 2024 is calculated as

Operating Cash Flow per Share (A: Mar. 2024 )=Cash Flow from Operations (A: Mar. 2024 )/Shares Outstanding (Diluted Average) (A: Mar. 2024 )
=163.224/13.649
=11.96

Ypsomed Holding AG's Operating Cash Flow per Share for the quarter that ended in Mar. 2024 is calculated as

Operating Cash Flow per Share (Q: Mar. 2024 )=Cash Flow from Operations (Q: Mar. 2024 )/Shares Outstanding (Diluted Average) (Q: Mar. 2024 )
=89.792/13.649
=6.58

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF11.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ypsomed Holding AG Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Ypsomed Holding AG's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Ypsomed Holding AG (XSWX:YPSN) Business Description

Traded in Other Exchanges
Address
Brunnmattstrasse 6, Burgdorf, CHE, 3401
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a unique click-on function. The company operates under two reportable segments: diabetes care and delivery systems goods and services. Diabetes care and delivery systems goods and services compose 55% and 40% of the company's sales, respectively.

Ypsomed Holding AG (XSWX:YPSN) Headlines

No Headlines